Literature DB >> 15183290

Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke.

Daphne Chan1, Daniela Caprara, Phillip Blanchette, Julia Klein, Gideon Koren.   

Abstract

The use of alcohol and tobacco is prevalent among pregnant women despite the well-known adverse effects of these substances imposed on the developing fetus and immense public health education efforts. Confirmation of gestational exposures to these compounds have relied mostly on maternal self-reporting, which is often underestimated because of guilt, embarrassment, and fear of punitive action. The presence of fatty acid ethyl esters in various biological matrices as a result of alcohol consumption initiated the development of neonatal screening tests for these emerging biological markers in meconium and hair. The levels of nicotine and cotinine in hair have long been used as objective indices for the quantification of exposure to active and passive smoking. Maternal segmental hair analysis in the study of pharmacokinetic changes in nicotine metabolism in the obstetric population is a novel application of this traditional analytical method. The latest developments and novel applications of meconium and hair testing for the confirmation of prenatal alcohol and tobacco exposure are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183290     DOI: 10.1016/j.clinbiochem.2004.01.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

1.  Directly measured second hand smoke exposure and asthma health outcomes.

Authors:  M D Eisner; J Klein; S K Hammond; G Koren; G Lactao; C Iribarren
Journal:  Thorax       Date:  2005-10       Impact factor: 9.139

Review 2.  Biomarkers in paediatric research and practice.

Authors:  B P Lanphear; C F Bearer
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

3.  Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect?

Authors:  Enrique M Ostrea; Joel D Hernandez; Dawn M Bielawski; Jack M Kan; Gregorio M Leonardo; Michelle Buda Abela; Michael W Church; John H Hannigan; James J Janisse; Joel W Ager; Robert J Sokol
Journal:  Alcohol Clin Exp Res       Date:  2006-07       Impact factor: 3.455

4.  The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes.

Authors:  Kristin B Ashford; Ellen Hahn; Lynne Hall; Mary Kay Rayens; Melody Noland; James E Ferguson
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2010 Sep-Oct

Review 5.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

6.  Does Maternal Exposure to Secondhand Tobacco Smoke During Pregnancy Increase the Risk for Preterm or Small-for-Gestational Age Birth?

Authors:  Adrienne T Hoyt; Mark A Canfield; Paul A Romitti; Lorenzo D Botto; Marlene T Anderka; Sergey V Krikov; Marcia L Feldkamp
Journal:  Matern Child Health J       Date:  2018-10

7.  Screening for fetal alcohol spectrum disorder.

Authors:  Joey Gareri; Daphne Chan; Julia Klein; Gideon Koren
Journal:  Can Fam Physician       Date:  2005-01       Impact factor: 3.275

Review 8.  Fetal Cerebral Circulation as Target of Maternal Alcohol Consumption.

Authors:  Anna N Bukiya; Alex M Dopico
Journal:  Alcohol Clin Exp Res       Date:  2018-05-09       Impact factor: 3.455

9.  Levels of cotinine in dried blood specimens from newborns as a biomarker of maternal smoking close to the time of delivery.

Authors:  Juan Yang; Michelle Pearl; Peyton Jacob; Gerald N DeLorenze; Neal L Benowitz; Lisa Yu; Christopher Havel; Martin Kharrazi
Journal:  Am J Epidemiol       Date:  2013-09-25       Impact factor: 4.897

10.  Potential role of the placenta in fetal alcohol spectrum disorder.

Authors:  Joey Gareri; James Brien; James Reynolds; Gideon Koren
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.